Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Loyola University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Loyola University
ClinicalTrials.gov Identifier:
NCT00756717
First received: September 19, 2008
Last updated: July 14, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: January 2012
  Estimated Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
No publications provided by Loyola University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):